Results 1 to 10 of about 736,894 (340)
Journal of Patient-Reported Outcomes, 2021 Background In 2019, an estimated 296 million people were living with chronic hepatitis B virus (HBV) globally with approximately 2.4 million living within the United States.
Catherine Freeland +6 more
doaj +1 more source
BMC Gastroenterology, 2022 Introduction In 2016 the World Health Organization (WHO) had adopted a global strategy to eliminate Hepatitis B (HBV) by 2030 through five core interventions.
Zhuo-zhi Lim +3 more
doaj +1 more source
Nature Reviews Disease Primers, 2022 Hepatic encephalopathy (HE) is a prognostically relevant neuropsychiatric syndrome that occurs in the course of acute or chronic liver disease. Besides ascites and variceal bleeding, it is the most serious complication of decompensated liver cirrhosis.
Dieter Häussinger +11 more
openaire +10 more sources
Archives of Public Health, 2021 Background Co-infection between hepatitis B virus (HBV) and hepatitis delta virus (HDV) causes the severest chronic hepatitis and is associated with a high risk of cirrhosis and hepatocellular carcinoma (HCC).
Tomoyuki Hayashi +10 more
doaj +1 more source
BMC Public Health, 2021 Background An estimated between 257 and 292 million people live with chronic HBV globally. While much is known about the causes, and epidemiology of HBV, little is understood about the quality of life and impact of HBV on those living with the infection.
Catherine Freeland +8 more
doaj +1 more source
Trends of the Global Hepatitis C Disease Burden: Strategies to Achieve Elimination [PDF]
Journal of Preventive Medicine and Public Health, 2021 Hepatitis C infection is responsible for high morbidity and mortality rates globally as well as for significant indirect costs. The disease burden caused by the hepatitis C virus (HCV) is comparable to the one caused by human immunodeficiency virus or ...
Nathalie Brunner, Philip Bruggmann
doaj +1 more source
Peer-facilitated treatment access for hepatitis C: the Live Hep C Free project
Harm Reduction Journal, 2022 Background This commentary explores the lessons learned during implementation of a peer-facilitated hepatitis C virus (HCV) testing and treatment access project called the Live Hep C Free (LHCF) project in contributing to micro-elimination efforts.
Julia A. Silano +4 more
doaj +1 more source
Nature Reviews Gastroenterology & Hepatology, 1996 Autoimmune hepatitis is an inflammatory liver disease in which the immune system is believed to orchestrate an immune attack onto the liver cell. Current knowledge suggests that both T helper 1 (TH1) and TH2 programmes are involved in the generation of the liver damage.
Vergani, D, Mieli-Vergani, G
openaire +12 more sources
BMC Infectious Diseases, 2023 Background and aims Refugees are at higher risk for hepatitis B (HBV) and hepatitis C (HCV), but often face unique healthcare barriers to vaccination, testing, and treatment.
Ankeeta Saseetharran +5 more
doaj +1 more source
Emerging Infectious Diseases, 2005 To the Editor: Hepatitis A virus (HAV) infection rates are very low in industrialized countries. A noticeable fall in the prevalence of HAV antibodies (anti-HAV) has been reported in southern European and Mediterranean countries such as Spain (1) and Greece (2), reflecting improvements in hygiene standards in the last decades.
D'AMELIO, Raffaele +7 more
openaire +6 more sources